Site Search
187 Results (showing 1 - 25)
Sep 28, 2001
Microarray startup NimbleGen, of Madison, Wisc., has nimbly coaxed open the tight purse strings of venture capitalists and raised an additional $9 million to fund its custom microarray program.
Sep 28, 2001
Micronics, a privately held microfluidics company in Redmond, Wash., has been developing a microfluidics microcytometry chip in collaboration with Honeywell that could be used as a mobile diagnostic device on a field soldier s wrist.
Sep 28, 2001
TRENDSPOTTER: The World Has Not Ended, It Has Just Changed
The terrorist attacks on the United States on Sept. 11 have changed a lot of things and exacerbated others. For one, they have changed us as a nation. Our beautiful home has been savagely attacked.
Sep 28, 2001
The September 7 BioArray News story, RNA Amplification Using T7 Method Gains Popularity as Commercial Version is Introduced, included a factual error.
Sep 28, 2001
PATENT WATCH: Sep 28, 2001
Premium
The University of Texas System, Motorola Life Sciences
Sep 28, 2001
Genomic Solutions Says Q3 Revenue Outlook Dims, Blames Attacks
NEW YORK, Sept. 28 - Genomic Solutions said on Friday that its third-quarter revenue might be half of what it originally expected, blaming shrinking orders and economic uncertainty in the wake of the attacks on the World Trade Center and the Pentagon on Sept.
Sep 28, 2001
University Expects to Complete Shotgun Mouse Sequence in December
BETHESDA, Md.- A Washington University researcher said he expects his team to complete the initial shotgun sequencing of the mouse genome by December.
Sep 28, 2001
The air freight slowdown and economic fluctuations in the wake of the Sept. 11 terrorist attacks in the US have not interrupted the growth trajectory of the biochip and microarray sector in any significant way, companies have told BioArray News.
Sep 28, 2001
NJ Med School Gets Army Contract to Define Molecular Signatures of Biological Warfare Agents
Premium
As concerns mount about preparedness for bioterrorism in the US, one microarray lab has already begun applying biochip technology to develop gene-based detection platforms for exposure to biological warfare agents.
Sep 28, 2001
AT A GLANCE
PhD in biochemistry from Cambridge University.
Postdoctoral fellowship at Stanford University. Research interests focus on applying flow cytometry and cell flow techniques to work in plant physiology.
Sep 28, 2001
Peter Wolstenholme has been appointed managing director of Stratagene Europe. Prior to joining Stratagene, Wolstenholme was vice president of sales and marketing at MWG Biotech.
Sep 28, 2001
Clondiag chip technologies of Jena, Germany, has released IconoClust, an array imaging software that allows automated analysis of both individual array images and groups of array images.
Sep 27, 2001
EBI s XEMBL Project Supports DoubleTwist s AGAVE Genomic Annotation Format
NEW YORK, Sept.
Sep 27, 2001
Shareholders Clear PerkinElmer Acquisition of Packard BioScience
NEW YORK, Sept. 27 - PerkinElmer is now one step closer to acquiring Packard BioScience after shareholders from both firms approved the deal, the companies said in a joint statement on Thursday.
Sep 26, 2001
Dresdner Kleinwort Wasserstein Begins Coverage of Genomic Sector
NEW YORK, Sept. 26 - Dresdner Kleinwort Wasserstein has begun covering a handful of “special niche” genomic and proteomic companies, the financial company said on Wednesday. The coverage, which will be led by analyst Charles C.
Sep 26, 2001
Packard Bioscience Enters Protein Array Market With HydroGel Product
NEW YORK, Sept. 26 - Packard Bioscience has launched its HydroGel coated slides for protein microarray applications, marking the company’s first protein array product, the company said on Wednesday.
Sep 26, 2001
Paradigm Reaches Milestone, Triggers Payment in Monsanto Agbio Deal
NEW YORK, Sept. 26 - Paradigm Genetics has met a fifth milestone in an agricultural gene-discovery partnership with Monsanto Company, triggering an undisclosed accelerated milestone payment, the functional genomics company said on Wednesday.